This publication summarises the key findings from the 8th round of the European School Survey Project on Alcohol and Other Drugs (ESPAD), which was conducted among 113 882 students aged 15 to 16, across 37 European countries in 2024. This edition marks 30 years of monitoring adolescent risky...

This report explores the foresight work carried out by the members of the EU Agencies Network for Scientific Advice (EU-ANSA) Futures Cluster between 2019 and 2024 - a period marked by heightened attention to foresight within the EU. Notably, this included the appointment of the first European...

The European Drug Report 2025: Trends and Developments presents the EUDA's latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report provides a comprehensive set of national data across these themes, as well as on specialist drug...

The purpose of this report, prepared jointly by the EUDA and the Regional Intelligence Liaison Office Western Europe (RILO-WE) of the World Customs Organization (WCO), is to support the actions implemented under the European Ports Alliance Public-Private Partnership (the European Ports Alliance)...

2-(Ethylamino)-1-phenylpentan-1-one (N-Ethylnorpentedrone, NEP) is a synthetic cathinone stimulant. It is N-alkylated cathinone, which is structurally related to methcathinone and pentedrone. In Europe, NEP is monitored by the EUDA as a new psychoactive substance through the EU Early Warning...

1-(4-Bromophenyl)-2-(methylamino)propan-1-one (4-bromomethcathinone, 4-BMC) is a synthetic cathinone stimulant. It is a ring-substituted cathinone, which is structurally related to methcathinone, 4-methylmethcathinone (mephedrone, 4-MMC), and 3-bromomethcathinone (3-BMC). In Europe, 4-BMC is...

2-(Methylamino)-1-(2-methylphenyl)propan-1-one (2-methylmethcathinone, 2-MMC) is a synthetic cathinone stimulant. It is a ring-substituted cathinone, which is structurally related to methcathinone, 4-methylmethcathinone (mephedrone) and 3-methylmethcathinone. In Europe, 2-MMC is monitored by the...

This publication summarises the key findings from the 8th round of the European School Survey Project on Alcohol and Other Drugs (ESPAD), which was conducted among 113 882 students aged 15- to 16-years-old, across 37 European countries in 2024. This edition marks 30 years of monitoring...

Illicit drug use and trafficking are global issues, threatening the health and security of EU citizens. Today's drug situation is complex, with potent substances being produced, trafficked and sold on an unprecedented scale. The European Union Drugs Agency (EUDA) plays a critical role in...

This report details the implementation of the European Union Drugs Agency's (EUDA) 2024 work programme, the first year of the multiannual Single Programming Document (SPD) 2024-2026. Closely aligned with the EMCDDA Strategy 2025, the report reflects the Agency's activities across its three core...